You have 9 free searches left this month | for more free features.

Advanced pretreated soft tissue sarcomas

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Carcinoma, Soft Tissue Sarcoma Trial in Bordeaux, Lyon (Combination of trabectedin with durvalumab)

Active, not recruiting
  • Ovarian Carcinoma
  • Soft Tissue Sarcoma
  • Combination of trabectedin with durvalumab
  • Bordeaux, France
  • +1 more
May 4, 2021

Soft-tissue Sarcomas Trial in Bordeaux (Phase 1: Trabectedin, Phase 2: Trabectedin, Phase 1: Cyclophosphamide)

Active, not recruiting
  • Soft-tissue Sarcomas
  • Phase 1: Trabectedin
  • +3 more
  • Bordeaux, France
    Institut Bergonié
May 4, 2021

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • (no location specified)
Apr 11, 2023

Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • Soft Tissue Sarcomas
  • Miami, Florida
    University of Miami
Dec 29, 2022

Effectiveness, Sexuality Trial in Zhengzhou (Lenvatinib mesylate capsule)

Not yet recruiting
  • Effectiveness
  • Sexuality
  • Lenvatinib mesylate capsule
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Jan 31, 2023

Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Advanced Soft Tissue Sarcoma
  • doxorubicin with AGEN1884 and AGEN2034
  • Aurora, Colorado
    University of Colorado Hospital
Jan 4, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Protocol For Bone and Soft Tissue Sarcomas

Completed
  • Sarcomas
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Apr 11, 2023

    Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

    Active, not recruiting
    • Liposarcoma
    • Metastatic Liposarcoma
    • Boston, Massachusetts
    • +2 more
    Nov 23, 2022

    Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

    Not yet recruiting
    • Advanced Soft-tissue Sarcoma
    • (no location specified)
    May 26, 2023

    Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • +5 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Sep 16, 2022

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023

    Sarcoma,Soft Tissue Trial in Helsinki (ultra-low-dose computed tomography)

    Completed
    • Sarcoma,Soft Tissue
    • ultra-low-dose computed tomography
    • Helsinki, Valitse Alue, Osavaltio Tai Maakunta, Finland
      Helsinki University Hospital Comprehensive Cancer Center
    Apr 14, 2023

    Soft Tissue Sarcoma Trial in Guangzhou (Toripalimab Combined With CAV / IE Regimen chemo)

    Recruiting
    • Soft Tissue Sarcoma
    • Toripalimab Combined With CAV / IE Regimen chemotherapy
    • Guangzhou, China
      Sun Yat-sen University Cancer Center
    Sep 4, 2022

    Advanced Soft-tissue Sarcoma, Advanced L-sarcomas, Other Advanced Sarcomas Trial in Zaragoza, Barcelona, Madrid (PM14)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • +4 more
    • Zaragoza, Aragón, Spain
    • +3 more
    Jun 30, 2022

    Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

    Terminated
    • Soft-tissue Sarcoma
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Sep 19, 2022

    Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)

    Recruiting
    • Neoadjuvant
    • +3 more
    • Pembrolizumab, Eftilagimod alpha
    • Warsaw, Poland
      Maria Sklodowska-Curie National Research Institute of Oncology
    Nov 7, 2023

    Soft Tissue Sarcoma Adult Trial in Montréal (Hypofractionation)

    Recruiting
    • Soft Tissue Sarcoma Adult
    • Hypofractionation
    • Montréal, Quebec, Canada
      McGill University Health Centre-Cedars Cancer Centre
    Sep 6, 2022

    Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Metastatic Soft-tissue Sarcoma
    • Bordeaux, France
    • +4 more
    May 5, 2022

    Soft-tissue Sarcoma, Predictive Cancer Model Trial in Netherlands (Care with the use of PERSARC, standard care)

    Recruiting
    • Soft-tissue Sarcoma
    • Predictive Cancer Model
    • Care with the use of PERSARC
    • standard care
    • Nijmegen, Gelderland, Netherlands
    • +6 more
    Feb 14, 2023

    Soft Tissue Sarcoma Trial in Madison (Conventional Fractionated, Hypofractionated)

    Recruiting
    • Soft Tissue Sarcoma
    • Conventional Fractionated
    • Hypofractionated
    • Madison, Wisconsin
      University of Wisconsin Hospital and Clinics
    May 6, 2022

    Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical

    Completed
    • Sarcoma
      • Irvine, California
        Beckman Laser Institute
      Oct 28, 2022

      Soft Tissue Sarcoma Trial in France (drug, combination product, other)

      Recruiting
      • Soft Tissue Sarcoma
      • Bordeaux, France
      • +17 more
      Oct 4, 2022

      Soft Tissue Sarcoma Trial in Madison (Hypofractionated Radiotherapy)

      Recruiting
      • Soft Tissue Sarcoma
      • Hypofractionated Radiotherapy
      • Madison, Wisconsin
        University of Wisconsin
      Mar 3, 2022